Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can father groups help dads bond with premature babies?

NCT ID NCT06116747

Symptom relief Sponsor: Hvidovre University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 18, 2026 · Last updated Sep 18, 2026

Summary

This study tests a support program for first-time fathers of premature infants in Denmark. The program aims to boost fathers' confidence and involvement by offering father groups, guidance from health professionals, and information about their baby's emotional, nutritional, and developmental needs. Researchers will measure fathers' confidence, stress, and family functioning, and compare results with usual care. Seven hospitals across Denmark take part, involving about 915 families.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A support program for first-time fathers of preterm infants, including father groups and guidance from health professionals
What this could lead to
If the program helps, hospitals could adopt similar support for fathers of premature babies, potentially improving paternal confidence and family wellbeing.
What could go wrong
The study uses a quasi-experimental design without random assignment, so any improvements may stem from other factors. Results may not apply outside Denmark's healthcare system.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 915 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2023

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * First-time fathers of preterm infants * Co-habitating with the mother of the infant * Neonatal Admission for more than seven days * Danish language * Infants born before the 37 week of gestation Exclusion Criteria: * Infant receiving palliative treatment and care * parents not discharged for home * parental mental illness

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Father-child relations are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Father-child relations Preterm

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Copenhagen University Hospital Amager Hvidovre

    Hvidovre, Hvidovre, 2650, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.